- Home
- TALO vs BHVN Comparison
TALO vs BHVN Comparison
Compare TALO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- BHVN
- Stock Information
- Founded
- TALO 2011
- BHVN 2013
- Country
- TALO United States
- BHVN United States
- Employees
- TALO N/A
- BHVN N/A
- Industry
- TALO Oil & Gas Production
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- TALO Energy
- BHVN Health Care
- Exchange
- TALO Nasdaq
- BHVN Nasdaq
- Market Cap
- TALO 1.7B
- BHVN 1.9B
- IPO Year
- TALO N/A
- BHVN 2017
- Fundamental
- Price
- TALO $10.77
- BHVN $7.86
- Analyst Decision
- TALO Buy
- BHVN Strong Buy
- Analyst Count
- TALO 6
- BHVN 16
- Target Price
- TALO $14.50
- BHVN $37.07
- AVG Volume (30 Days)
- TALO 1.7M
- BHVN 5.3M
- Earning Date
- TALO 11-05-2025
- BHVN 11-10-2025
- Dividend Yield
- TALO N/A
- BHVN N/A
- EPS Growth
- TALO N/A
- BHVN N/A
- EPS
- TALO N/A
- BHVN N/A
- Revenue
- TALO $1,872,554,000.00
- BHVN N/A
- Revenue This Year
- TALO N/A
- BHVN N/A
- Revenue Next Year
- TALO N/A
- BHVN $2,079.03
- P/E Ratio
- TALO N/A
- BHVN N/A
- Revenue Growth
- TALO 0.06
- BHVN N/A
- 52 Week Low
- TALO $6.23
- BHVN $7.48
- 52 Week High
- TALO $12.13
- BHVN $51.81
- Technical
- Relative Strength Index (RSI)
- TALO 64.72
- BHVN 27.62
- Support Level
- TALO $10.37
- BHVN $7.48
- Resistance Level
- TALO $10.81
- BHVN $8.77
- Average True Range (ATR)
- TALO 0.38
- BHVN 1.11
- MACD
- TALO 0.10
- BHVN -0.74
- Stochastic Oscillator
- TALO 90.02
- BHVN 3.47
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.